Sulfathiazole sodium is an analytical standard suitable for research and analytical applications such as HPLC, GC, and MS. It acts as an orally active endocrine disruptor, notably enhancing CYP19 activity in human adrenal cancer cells (H295R) and upregulating the mRNA expression of CYP17, CYP19, and 3β-HSD. The compound also increases 17-estradiol (E2) production and exhibits endocrine disrupting effects on aquatic organisms. Furthermore, it functions as a cathodic corrosion inhibitor by reducing corrosion current density and shifting corrosion potential negatively.
- Enhances CYP19 activity in human adrenal cancer cells
- Upregulates mRNA expression of CYP17, CYP19, and 3β-HSD
- Increases 17-estradiol (E2) production
- Exhibits endocrine disrupting effects on aquatic organisms
- Inhibits copper corrosion by chloride ions